Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
Handbook on Adolescent & Adult Immunization
A Parthasarathy, Alok Gupta
CHAPTER 1:
PRINCIPLES, PRACTICES AND ISSUES IN ADOLESCENT VACCINATION
INTRODUCTION
BARRIERS FOR ADOLESCENT IMMUNIZATION
Unique Group
Lack of Awareness
Adolescents will go to a Variety of Caregivers
Parental Consent
Communication
Documentation
INDIAN SCENARIO OF ADOLESCENT VACCINATIONS14
REASONS FOR IMMUNIZATION IN ADOLESCENTS19
ISSUES IN ADOLESCENT IMMUNIZATION13
Immunological Aspects13
Childhood Immunizations Taken
Boosters and Extra Doses of Vaccines Already Given as Earlier Immunizations
Ascertaining the Pregnancy Status of Adolescent Girls before Vaccination14
Psychological Aspects of Adolescent Immunization
HIV Infected Adolescents
Flexibility of Vaccine Scheduling in Adolescents
Simultaneous Administration of Vaccines
OUR EXPERIENCE FOR RECOMMENDATION FOR ADOLESCENTS IN INDIA14
Adolescents from Higher Socioeconomic Group14
Adolescents Belonging to the Lower Socio-economic Group14
Newer Vaccines Available to Counter a Specific Risk
STRATEGIES FOR IMPROVING ADOLESCENT IMMUNIZATION
Schedule a Well Adolescent Visit at 11–12 Years23
School and College Health Programs
Increasing Awareness in Parents
Increasing Awareness in Adolescents Themselves
Increasing Awareness in Providers14
Public Health Strategies for Mass Immunization of Adolescents14
Public Awareness
SUMMARY
CHAPTER 2:
PRINCIPLE AND ISSUES IN ADULT IMMUNIZATION
INTRODUCTION
ROUTINE PREVENTABLE VACCINES FOR ADULTS
VACCINES AND PREGNANCY
VACCINES AND ADULTS
MAY NEED VACCINE WHEN YOU TRAVEL
BARRIERS TO ADULT IMMUNIZATION
ACTIONS TO SUPPORT ADULT IMMUNIZATION
SUMMARY
ACKNOWLEDGMENT
CHAPTER 3.1:
ADOLESCENT VACCINES
INTRODUCTION
3.1.1: CATCH UP VACCINES
3.1.1.1: Hepatitis A Vaccine
3.1.1.2: Hepatitis B Vaccine
3.1.1.2.1: Why Booster Doses are not Required for Hepatitis B Vaccine?
3.1.1.2.2: Hepatitis B Vaccine Immunogenicity of Schedules
3.1.1.3: Measles, Mumps, Rubella Vaccine
3.1.1.4: Varicella Vaccine
3.1.1.5: Typhoid Vaccine
3.1.1.6: DT/TT/Td/Tdap Vaccines
3.1.2: TRUE ADOLESCENT VACCINES
3.1.2.1: Human Papillomavirus Vaccine
3.1.3: HIGH RISK CATEGORY VACCINE
3.1.3.1: Pneumococcal Vaccine
3.1.4: VACCINE FOR HYPER ENDEMIC REGION
3.1.4.1: Japanese Encephalitis Vaccine
3.1.5: EPIDEMIC ALERT VACCINES
Influenza Vaccine
3.1.6: TRAVEL RELATED VACCINES
3.1.6.1: Meningococcal Vaccine
3.1.6.2: Yellow Fever Vaccine
3.1.6.3: Rabies Vaccine
FUTURE PREDICTED VACCINE SCHEDULE 2025 (PLOTKIN)
CHAPTER 3.2:
ADULT VACCINES
INTRODUCTION
DIPHTHERIA, TETANUS AND PERTUSSIS VACCINES
HEPATITIS A VACCINES
HEPATITIS B VACCINES
HERPES ZOSTER VACCINES
HUMAN PAPILLOMAVIRUS VACCINES
INFLUENZA VACCINES
MEASLES, MUMPS AND RUBELLA VACCINES
MENINGOCOCCAL VACCINES
PNEUMOCOCCAL VACCINES
RABIES VACCINES
TYPHOID VACCINES
VARICELLA VACCINE
SUMMARY
ACKNOWLEDGMENT
CHAPTER 4.1:
ADOLESCENT IMMUNIZATION SCHEDULES
4.1.1: IMMUNIZATION SCHEDULES
a. FAQ's by Doctors:
b. FAQs by Parents:
4.1.1.1: IAP recommended Vaccines for High-risk* Adolescents (Vaccines Under Special Circumstances):
* High-risk Category of Children and Other Persons
4.1.1.2: Schedule Recommended for Adolescent Travelers
CHAPTER 4.2:
YOU ARE NEVER TOO OLD TO GET IMMUNIZED
4.2.1: INTRODUCTION
SUMMARY
CHAPTER 5:
FUTURE VACCINES FOR ADOLESCENT AND ADULT IMMUNIZATION
INTRODUCTION
NEW VACCINES FOR FUTURE
Dengue Vaccine
Malaria Vaccine
HIV Vaccine
Hepatitis E Vaccine
Hepatitis C Vaccine
Oral Cholera Vaccine
Cytomegalovirus Vaccine
Epstein-Barr Virus Vaccine
Vaccine for Leishmaniasis
CHALLENGES IN FUTURE VACCINATION
STRATEGIES FOR IMPROVEMENT IN VACCINATION
SUMMARY
ACKNOWLEDGMENT
CHAPTER 6:
ADVERSE EVENTS FOLLOWING IMMUNIZATION
VACCINE SAFETY—A UNIVERSAL CONCERN
WHO RECOMMENDATIONS TO MINIMIZE AEFI
Prevention of Acute Vaccine Reactions
CAUSES AND ERRORS LEADING TO AEFI
VACCINES AND CONTRAINDICATIONS
ANAPHYLAXIS AND DRUGS
Epinephrine in the treatment of anaphylaxis Subcutaneous or intramuscular administration
DOSAGES OF COMMONLY USED SECONDARY DRUGS IN THE TREATMENT OF ANAPHYLAXIS
THREATS TO IMMUNIZATION—SAFETY CONCERNS
AEFI: PRACTICAL GUIDELINES
Precautions
COMMON ADVERSE EVENTS TO VACCINES
BCG Vaccine
DTPw/DTPa Vaccine
Hib Conjugate Vaccine
Hepatitis A Vaccine
Hepatitis B Vaccine
Human papillomavirus Vaccine
H. Influenzae Vaccine/s (Live stock inactivated)
Japanese B Encephalitis Vaccine/s (Live stock inactivated)
Measles-Mumps-Rubella Vaccine
Meningococcal Vaccine
Pneumococal Vaccine (PCV, PPV)
Polio Vaccines (OPV, IPV)
Rabies Vaccine
Rabies Immunoglobulins (RIG)
Rotavirus Vaccine
Typhoid Vaccine
Varicella Zoster Vaccine
PENTAVAC
TAKE HOME MESSAGES AEFI PRACTICAL GUIDELINES
CHAPTER 7:
THE COLD CHAIN FOR VACCINES
THE COLD CHAIN
THE COLD CHAIN EQUIPMENTS
REFRIGERATORS
VACCINE VIAL MONITORS
Storage of Vaccines in Domestic Refrigerator
RECOMMENDED STORAGE OF COMMONLY USED VACCINES*
POWER FAILURE
SUMMARY
CHAPTER 8:
DISEASE SURVEILLANCE
INTRODUCTION
ACUTE FLACCID PARALYSIS SURVEILLANCE
Global and India Polio Eradication Initiative— Past, Present and Future
Recommendations
SIAs
Surveillance
Reducing Risk of Importation
IPV Introduction Process
INTEGRATED DISEASE SURVEILLANCE PROGRAM
REPORTING REQUIREMENT OF IDSP
Diseases under Surveillance by Health Providers
Method of Surveillance
REPORTING FORMAT FOR SENTINEL SITES
PRIVATE SECTOR COLLABORATION IN TB CONTROL PROGRAM
Quality Control
Method of Recruitment
Incentives
CHAPTER 9:
SAFE INJECTION PRACTICES
INTRODUCTION
PEOPLE PREFER INJECTIONS
WHAT IS A SAFE INJECTION?
DISEASES ASSOCIATED WITH UNSAFE INJECTION PRACTICES
WHAT NEEDS TO BE DONE TO CHANGE THIS SCENARIO
Association for Professional in Infection Control Recommendations
Syringes
Vials
Some General Points
CONCLUSION
POINTS TO REMEMBER
RATIONAL USE OF INJECTIONS
Points to Remember
BEST INFECTION CONTROL PRACTICES FOR INJECTIONS
METHOS OF INJECTION DELIVERY
Commandments of Right Injection Delivery
HANDWASHING
SITE SELECTION
Anterolateral Thigh
Deltoid Muscle
POSITIONING
CLEANSING
DO NOT TOUCH PARTS
SIZE AND BORE OF THE NEEDLE
Intradermal Injection
Intramuscular Injection
Subcutaneous Injection
Needle Bore (Gauge)
TECHNIQUES OF INJECTION ADMINISTRATION
WHO Recommended Techniques
Intradermal Injections
Intramuscular Injections
Subcutaneous Injections (Figs 9.8 and 9.9)
ACIP Recommended Techniques
Intradermal Injections
Subcutaneous Injections
Intramuscular Injections
Adolescents and Adults
Postinjection Precautions
Multiple Injections
POSTINJECTION CARE AND ANTICIPATORY GUIDANCE
EMERGENCY MANAGEMENT
POINTS TO REMEMBER
HEALTHCARE WORKER SAFETY
Points to Remember
Injection Waste Disposal
Objective
Challenge
Present Way of Sharp Management
Biomedical Waste Management Rules
What is Needed?
CLASSIFICATION OF HOSPITAL WASTE
What are Waste Sharps?
Color Coding
CPCB POLICY ON BMW MANAGEMENT
Sharp Waste Minimization
Segregation of Sharps
Where?
Handling of Sharps
Containers
Mutilation/Destruction/Shredding
Hub Cutter/Needle Destroyer
Shredders
Treatment and Disposal
Heat Disinfection
Encapsulation
Smelting
Burial
Incineration
Implementation
Waste Chain
Awareness
Scale-Up
Team Care and Responsibility
DO'S OF SHARPS WASTE MANAGEMENT
DON'TS OF SHARPS WASTE MANAGEMENT
GUIDELINES FOR CLINICS AND CONSULTANTS
POINTS TO REMEMBER
IAP RECOMMENDATIONS ON INJECTION SAFETY
Equipment Related
Safe Injection Practices
Some Specific Recommendations
State Government
Private Institutions
Individual Health Care Staff
POINTS TO REMEMBER
SPECIAL ACKNOWLEDGMENT
CHAPTER 10:
READY RECKONER
ANNEXURE:
IMMUNIZATION WEBSITES
INDEX
TOC
Index
×
Chapter Notes
Save
Clear